PIŚMIENNICTWO
1. Stratmann N, Failing K, Richter A, et al. Mammary tumor recurrence in bitches after regional mastectomy. Vet Surg. 2008;37(1):82-86. doi:10.1111/j.1532-950X.2007.00351.x
2. Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst. 1969;43(6):1249-1261.
3. Ghisleni G, Roccabianca P, Ceruti R, et al. Correlation between fine-needle aspiration cytology and histopathology in the evaluation of cutaneous and subcutaneous masses from dogs and cats. Vet Clin Pathol. 2006;35(1):24-30. doi:10.1111/j.1939-165x.2006.tb00084.x
4. Cohen M, Bohling MW, Wright JC, et al. Evaluation of sensitivity and specificity of cytologic examination: 269 cases (1999-2000). J Am Vet Med Assoc. 2003;222(7):964-967. doi:10.2460/javma.2003.222.964
5. Ehrhart N, Dernell WS, Hoffmann WE, et al. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). J Am Vet Med Assoc. 1998;213(7):1002-1006.
6. Bone appendicular OSA. Veterinary Society of Surgical Oncology. Accessed January 6, 2023. https://vsso.org/bone-appendicular-osa
7. Saam DE, Liptak JM, Stalker MJ, et al. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). J Am Vet Med Assoc. 2011;238(2):195-206. doi:10.2460/javma.238.2.195
8. Phillips B, Powers BE, Dernell WS, et al. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc. 2009;45(1):33-38. doi:10.5326/0450033
